Home/Filings/4/0001225208-24-005889
4//SEC Filing

Chopra Daveen 4

Accession 0001225208-24-005889

CIK 0001099800other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 7:40 PM ET

Size

11.3 KB

Accession

0001225208-24-005889

Insider Transaction Report

Form 4
Period: 2024-05-07
Chopra Daveen
CVP, TMTT
Transactions
  • Award

    Common Stock

    2024-05-07+7,00031,851 total
  • Tax Payment

    Common Stock

    2024-05-07$85.09/sh447$38,03531,404 total
  • Award

    Employee Stock Option (Right to Acquire)

    2024-05-07+37,20037,200 total
    Exercise: $85.84From: 2025-05-07Exp: 2031-05-06Common Stock (37,200 underlying)
  • Award

    Performance Rights

    2024-05-07+7,0007,000 total
    From: 2027-05-07Common Stock (7,000 underlying)
Footnotes (3)
  • [F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
  • [F2]These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
  • [F3]Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0001740963

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:40 PM ET
Size
11.3 KB